LY96/MD2 Polyclonal antibody

LY96/MD2 Polyclonal Antibody for IHC, WB,ELISA

Host / Isotype

Rabbit / IgG


human and More (2)





Cat no : 11784-1-AP


ESOP 1, ESOP1, Ly 96, LY96, lymphocyte antigen 96, MD 2, MD2, Protein MD 2

Tested Applications

Positive WB detected inU-937 cells
Positive IHC detected inhuman kidney tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

Western Blot (WB)WB : 1:500-1:1000
Immunohistochemistry (IHC)IHC : 1:20-1:200
Sample-dependent, check data in validation data gallery

Published Applications

WBSee 3 publications below

Product Information

11784-1-AP targets LY96/MD2 in WB, IHC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen LY96/MD2 fusion protein Ag2447
Full Name lymphocyte antigen 96
Calculated molecular weight 160 aa, 18 kDa
Observed molecular weight 20 kDa and 30 kDa and 35 kDa
GenBank accession numberBC020690
Gene symbol LY96
Gene ID (NCBI) 23643
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

LY96, also named as ESOP1 or MD 2, is a small secreted glycoprotein that can bind to both the hydrophobic portion of LPS and to the extracellular domain of TLR4. The interaction between MD-2 and LPS bridges the two TLR4 molecules and induces the dimerization of LPS-MD-2-TLR4, which forms the structural basis for biological functions of TLR4/MD-2 complex. Due to its essential role in mediating the interaction between LPS and TLR4, MD-2 has been extensively explored as a therapeutic target for treatment of inflammatory disorders.


Product Specific Protocols
WB protocol for LY96/MD2 antibody 11784-1-APDownload protocol
IHC protocol for LY96/MD2 antibody 11784-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols



Oncol Rep

Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways.

Authors - Lanfeng Zhang


Sal B Alleviates Myocardial Ischemic Injury by Inhibiting TLR4 and the Priming Phase of NLRP3 Inflammasome.

Authors - Yang Hu

J Cardiovasc Transl Res

Macrophage CD36 and TLR4 Cooperation Promotes Foam Cell Formation and VSMC Migration and Proliferation Under Circadian Oscillations.

Authors - Zhen Sun

Front Oncol

MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas.

Authors - Mengya Zhao